These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9862763

  • 1. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
    Kim CD, Kim HH, Hong KW.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
    [Abstract] [Full Text] [Related]

  • 2. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD, Hong KW.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
    [Abstract] [Full Text] [Related]

  • 3. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    Masamune A, Yoshida M, Sakai Y, Shimosegawa T.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
    [Abstract] [Full Text] [Related]

  • 4. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
    Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M.
    Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
    [Abstract] [Full Text] [Related]

  • 5. In vitro studies indicating antioxidative properties of rebamipide.
    Iinuma S, Naito Y, Yoshikawa T, Takahashi S, Takemura T, Yoshida N, Kondo M.
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
    Yoshida N, Yoshikawa T, Iinuma S, Arai M, Takenaka S, Sakamoto K, Miyajima T, Nakamura Y, Yagi N, Naito Y, Mukai F, Kondo M.
    Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
    Yoshida N, Ishikawa T, Ichiishi E, Yoshida Y, Hanashiro K, Kuchide M, Uchiyama K, Kokura S, Ichikawa H, Naito Y, Yamamura Y, Okanoue T, Yoshikawa T.
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
    [Abstract] [Full Text] [Related]

  • 13. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
    Danielsson D, Jurstrand M.
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
    [Abstract] [Full Text] [Related]

  • 14. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
    Yamamichi N, Oka M, Inada K, Konno-Shimizu M, Kageyama-Yahara N, Tamai H, Kato J, Fujishiro M, Kodashima S, Niimi K, Ono S, Tsutsumi Y, Ichinose M, Koike K.
    Biochem Biophys Res Commun; 2012 Jul 20; 424(1):124-9. PubMed ID: 22732404
    [Abstract] [Full Text] [Related]

  • 15. Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
    Matysiak-Budnik T, Thomas-Collignon A, Mégraud F, Heyman M.
    Dig Dis Sci; 2001 Jul 20; 46(7):1558-66. PubMed ID: 11478510
    [Abstract] [Full Text] [Related]

  • 16. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
    Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A.
    Dig Dis Sci; 1998 Sep 20; 43(9 Suppl):5S-13S. PubMed ID: 9753220
    [Abstract] [Full Text] [Related]

  • 17. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S, Sugiyama T, Amano K, Isogai H, Isogai E, Aihara M, Kikuchi M, Asaka M, Yokota K, Oguma K, Fujii N, Hirai Y.
    Antimicrob Agents Chemother; 1998 Aug 20; 42(8):1895-9. PubMed ID: 9687380
    [Abstract] [Full Text] [Related]

  • 18. Rebamipide inhibits neutrophil adhesion to hypoxia/reoxygenation-stimulated endothelial cells via nuclear factor-kappaB-dependent pathway.
    Kim CD, Kim YK, Lee SH, Hong KW.
    J Pharmacol Exp Ther; 2000 Sep 20; 294(3):864-9. PubMed ID: 10945834
    [Abstract] [Full Text] [Related]

  • 19. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
    Kim CD, Hong KW.
    J Pharmacol Exp Ther; 1995 Oct 20; 275(1):340-4. PubMed ID: 7562569
    [Abstract] [Full Text] [Related]

  • 20. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
    Han BG, Kim HS, Rhee KH, Han HS, Chung MH.
    Pharmacol Res; 1995 Oct 20; 32(4):201-7. PubMed ID: 8866835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.